Although the expression level of S100A6 is significantly increased in human and mouse CCA tumor samples, the serum level of S100A6 is not changed in patients with CCA; therefore, it is not suitable for the diagnosis of CCA. The gene discussed is S100A6; the disease is cholangiocarcinoma.